1.Phthalates Action Plan, U.S.E.P. Agency, Editor. 2012.
2.Benjamin, S, Masai, E, Kamimura, N, Takahashi, K, Anderson, RC, Faisal, PA. Phthalates impact human health: epidemiological evidences and plausible mechanism of action. J Hazard Mater. 2017; 340, 360–383.
3.Wittassek, M, Angerer, J. Phthalates: metabolism and exposure. Int J Androl. 2008; 31, 131–138.
4.Latini, G, De Felice, C, Verrotti, A. Plasticizers, infant nutrition and reproductive health. Reprod Toxicol. 2004; 19, 27–33.
5.Frederiksen, H, Skakkebaek, NE, Andersson, AM. Metabolism of phthalates in humans. Mol Nutr Food Res. 2007; 51, 899–911.
6.Inada, H, Chihara, K, Yamashita, A, et al.Evaluation of ovarian toxicity of mono-(2-ethylhexyl) phthalate (MEHP) using cultured rat ovarian follicles. J Toxicol Sci. 2012; 37, 483–490.
7.Tomita, I, Nakamura, Y, Yagi, Y, Tutikawa, K. Fetotoxic effects of mono-2-ethylhexyl phthalate (MEHP) in mice. Environ Health Perspect. 1986; 65, 249–254.
8.Guibert, E, Prieur, B, Cariou, R, et al.Effects of mono-(2-ethylhexyl) phthalate (MEHP) on chicken germ cells cultured in vitro. Environ Sci Pollut Res. 2013; 20, 2771–2783.
9.Jacobs, HM, Sant, KE, Basnet, A, Williams, LM, Moss, JB, Timme-Laragy, AR. Embryonic exposure to Mono(2-ethylhexyl) phthalate (MEHP) disrupts pancreatic organogenesis in zebrafish (Danio rerio). Chemosphere. 2018; 195, 498–507.
10.Sant, KE, Dolinoy, DC, Jilek, JL, Sartor, MA, Harris, C. Mono-2-ethylhexyl phthalate disrupts neurulation and modifies the embryonic redox environment and gene expression. Reprod Toxicol. 2016; 63, 32–48.
11.Swan, SH, Sathyanarayana, S, Barrett, ES, et al.First trimester phthalate exposure and anogenital distance in newborns. Human Reproduction (Oxford, England) 2015; 30, 963–972.
12.Sathyanarayana, S, Barrett, E, Nguyen, R, Redmon, B, Haaland, W, Swan, SH. First trimester phthalate exposure and infant birth weight in the infant development and environment study. Int J Environ Res Public Health 2016; 13, 945.
13.Harley, KGBerger, K, Rauch, S, et al. Association of prenatal urinary phthalate metabolite concentrations and childhood BMI and obesity. Pediatr Res. 2017; 82, 405–415.
14.Heindel, JJ. History of the obesogen field: looking back to look forward. Front Endocrinol. 2019; 10, 14–14.
15.Heindel, JJ, Blumberg, B. Environmental obesogens: mechanisms and controversies. Annu Rev Pharmacol Toxicol. 2019; 59, 89–106.
16.Grün, F, Blumberg, B. Endocrine disrupters as obesogens. Mol Cell Endocrinol. 2009; 304, 19–29.
17.Grün, F, Blumberg, B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology. 2006; 147, s50–s55.
18.Wang, W, Craig, ZR, Basavarajappa, MS, Hafner, KS, Flaws, JA. Mono-(2-ethylhexyl) phthalate induces oxidative stress and inhibits growth of mouse ovarian antral follicles. Biol Reprod. 2012; 87, 152–152.
19.Pi, J, Leung, L, Xue, P, et al.Deficiency in the nuclear factor E2-related Factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J Biol Chem. 2010; 285, 9292–9300.
20.Sheikh, IA, Abu-Elmagd, M, Turki, RF, Damanhouri, GA, Beg, MA, Al-Qahtani, M. Endocrine disruption: in silico perspectives of interactions of di-(2-ethylhexyl)phthalate and its five major metabolites with progesterone receptor. BMC Struct Biol. 2016; 16(Suppl. 1), 16–16.
21.Zhai, W, Huang, Z, Chen, L, Feng, C, Li, B, Li, T. Thyroid endocrine disruption in zebrafish larvae after exposure to mono-(2-Ethylhexyl) phthalate (MEHP). PLoS One. 2014; 9, e92465.
22.Shelton, P, Jaiswal, AK. The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene? FASEB J. 2013; 27, 414–423.
23.Kwong, M, Kan, YW, Chan, JY. The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents. Role for Nrf1 in gamma-gcs(l) and gss expression in mouse fibroblasts. J Biol Chem. 2000; 274; 37491–37498.
24.Sykiotis, GP, Bohmann, D. Stress-activated cap’n’collar transcription factors in aging and human disease. Sci Signal. 2010; 3, re3–re3.
25.Ma, Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013; 53, 401–426.
26.Espinosa-Diez, C, Miguel, V, Mennerich, D, et al.Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol. 2015; 6, 183–197.
27.Timme-Laragy, AR, Karchner, SI, Franks, DG, et al.Nrf2b, novel zebrafish paralog of oxidant-responsive transcription factor NF-E2-related factor 2 (NRF2). J Biol Chem. 2012; 287, 4609–4627.
28.Kobayashi, M, Itoh, K, Suzuki, T, et al.Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system. Genes Cells. 2002; 7, 807–820.
29.Sant, KE, et al.Nrf2a modulates the embryonic antioxidant response to perfluorooctanesulfonic acid (PFOS) in the zebrafish, Danio rerio. Aquat Toxicol. 2018; 198, 92–102.
30.Sant, KE, et al. The role of Nrf1 and Nrf2 in the regulation of glutathione and redox dynamics in the developing zebrafish embryo. Redox Biol. 2017; 13 (Suppl. C), 207–218.
31.Furukawa, S, Fujita, T, Shimabukuro, M, et al.Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114, 1752–1761.
32.Marseglia, L, Manti, S, D’Angelo, G, et al.Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2014; 16, 378–400.
33.Takahashi, T, et al.Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism. Biochem Biophys Res Commun. 2009; 382, 549–554.
34.Shin, S, Wakabayashi, J, Yates, MS, et al.Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide. Eur J Pharmacol. 2009; 620, 138–144.
35.Seo, H-A, Lee, I-K. The role of Nrf2: adipocyte differentiation, obesity, and insulin resistance. Oxid Med Cell Longevity. 2013; 2013, 184598–184598.
37.Benedict, M, Zhang, X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol. 2017; 9, 715–732.
38.Sayiner, M, et al., Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clin Liver Dis. 2016; 20, 205–214.
39.Arciello, M, Gori, M, Maggio, R, et al.Environmental pollution: a tangible risk for NAFLD pathogenesis. Int J Mol Sci. 2013; 14.
40.Mukaigasa, K, et al.Genetic evidence of an evolutionarily conserved role for Nrf2 in the protection against oxidative stress. Mol Cell Biol. 2012; 32, 4455–4461.
41.Rousseau, ME, et al.Regulation of Ahr signaling by Nrf2 during development: effects of Nrf2a deficiency on PCB126 embryotoxicity in zebrafish (Danio rerio). Aquat Toxicol. (Amsterdam, Netherlands) 2015; 167, 157–171.
42.Schlegel, A, Stainier, DYR. Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae. Biochemistry. 2006; 45, 15179–15187.
43.Fraher, D, et al. Lipid abundance in zebrafish embryos is regulated by complementary actions of the endocannabinoid system and retinoic acid pathway. Endocrinology. 2015; 156, 3596–3609.
44.Livak, KJ, Schmittgen, TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001; 25, 402–408.
45.McCurley, AT, Callard, GVJBMB. Characterization of housekeeping genes in zebrafish: male-female differences and effects of tissue type, developmental stage and chemical treatment. BMC Mol Biol. 2008; 9, 102.
46.Cooper, CA, Handy, RD, Bury, NR. The effects of dietary iron concentration on gastrointestinal and branchial assimilation of both iron and cadmium in zebrafish (Danio rerio). Aquat Toxicol. 2006; 79, 167–175.
47.Zhao, X, et al.Klf6/copeb is required for hepatic outgrowth in zebrafish and for hepatocyte specification in mouse ES cells. Dev Biol. 2010; 344, 79–93.
48.Laprairie, RB, Denovan-Wright, EM, Wright, JM. Subfunctionalization of peroxisome proliferator response elements accounts for retention of duplicated fabp1 genes in zebrafish. BMC Evol Biol. 2016; 16, 147.
49.Schultz, LE, et al.Epigenetic regulators Rbbp4 and Hdac1 are overexpressed in a zebrafish model of RB1 embryonal brain tumor, and are required for neural progenitor survival and proliferation. Dis Model Mech. 2018; 11, dmm034124.
50.Williams, LM, et al.Developmental expression of the Nfe2-related factor (Nrf) transcription factor family in the Zebrafish, Danio rerio. PLoS One. 2013; 8, e79574.
51.Williams, LM, et al.The transcription factor, Nuclear factor, erythroid 2 (Nfe2), is a regulator of the oxidative stress response during Danio rerio development. Aquat Toxicol. (Amsterdam, Netherlands) 2016; 180, 141–154.
52.Cederbaum, AI, Nrf2 and antioxidant defense against CYP2E1 toxicity. In Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism (ed. Dey, A), 2013; pp. 105–130. Springer Netherlands, Dordrecht.
53.Thisse, B, et al. Expression of the zebrafish genome during embryogenesis (NIH R01 RR15402), in ZFIN Direct Data Submission (http://zfin.org). 2001.
54.Fagerberg, L, et al.Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014; 13, 397–406.
55.Feige, JN, et al.The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor γ modulator that promotes adipogenesis. J Biol Chem. 2007; 282, 19152–19166.
56.Hurst, CH, Waxman, DJ. Activation of PPARα and PPARγ by environmental phthalate monoesters. Toxicol Sci. 2003; 74, 297–308.
57.Sant, KE, et al.Embryonic exposures to perfluorooctanesulfonic acid (PFOS) disrupt pancreatic organogenesis in the zebrafish, Danio rerio. Environ Pollut. 2017; 220, 807–817.
58.Fenton, TR, Kim, JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013; 13, 59.
59.Dulloo, AG, et al.The thrifty ‘catch-up fat’ phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. Int J Obes. 2006; 30, S23–S35.
60.Vaag, A. Low birth weight and early weight gain in the metabolic syndrome: consequences for infant nutrition. Int J Gynecol Obstet. 2009; 104 (Supplement), S32–S34.
61.Simmons, R. Developmental origins of adult metabolic disease: concepts and controversies. Trends Endocrinol Metabol. 2005; 16, 390–394.
62.Pan, L, et al.Trends in severe obesity among children aged 2 to 4 years enrolled in special supplemental nutrition program for women, infants, and children from 2000 to 2014 trends in severe obesity among US children aged 2 to 4 years enrolled in WICTrends in severe obesity among US children aged 2 to 4 years enrolled in WIC. JAMA Pediatr. 2018; 172, 232–238.
63.Fryar, CD, Carroll, MD, Ogden, CL. Prevalence of Overweight and Obesity among Children and Adolescents: United States, 1963–1965 Through 2011–2012, N.C.f.H. Statistics, Editor. 2014, Centers for Disease Control and Prevention, Division of Health and Nutrition Examination Surveys. Hyattsville, MD.
64.Bai, J, et al.Mono-2-ethylhexyl phthalate induces the expression of genes involved in fatty acid synthesis in HepG2 cells. Environ Toxicol Pharmacol. 2019; 69, 104–111.
65.Zhang, Y, et al.Mono-2-ethylhexyl phthalate (MEHP) promoted lipid accumulation via JAK2/STAT5 and aggravated oxidative stress in BRL-3A cells. Ecotoxicol Environ Saf. 2019; 184, 109611.
66.Pereira, C, Mapuskar, K, Rao, CV. Chronic toxicity of diethyl phthalate in male Wistar rats – a dose–response study. Regul Toxicol Pharm. 2006; 45, 169–177.
67.Ibabe, A, Bilbao, E, Cajaraville, MP. Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio) depending on gender and developmental stage. Histochem Cell Biol. 2005; 123, 75–87.
68.Liss, KHH, Finck, BN. PPARs and nonalcoholic fatty liver disease. Biochimie. 2017; 136, 65–74.
69.Liew, WC, et al.Polygenic sex determination system in zebrafish. PLoS One. 2012; 7, e34397–e34397.
70.Uchida, D, et al.Oocyte apoptosis during the transition from ovary-like tissue to testes during sex differentiation of juvenile zebrafish. J Exp Biol. 2002; 205, 711–718.
71.Phillips, ML. Phthalates and metabolism: exposure correlates with obesity and diabetes in men. Environ Health Perspect. 2007; 115, A312–A312.
72.Ballestri, S, et al.NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Therapy. 2017; 34, 1291–1326.
73.Bertolotti, M, et al.Nonalcoholic fatty liver disease and aging: epidemiology to management. World J Gastroenterol. 2014; 20, 14185–14204.